These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38212510)

  • 1. Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer.
    Fang AM; Jackson J; Gregg JR; Chery L; Tang C; Surasi DS; Siddiqui BA; Rais-Bahrami S; Bathala T; Chapin BF
    Curr Treat Options Oncol; 2024 Jan; 25(1):66-83. PubMed ID: 38212510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of high-risk, localized prostate cancer.
    Wilkins LJ; Tosoian JJ; Sundi D; Ross AE; Grimberg D; Klein EA; Chapin BF; Nyame YA
    Nat Rev Urol; 2020 Dec; 17(12):679-690. PubMed ID: 33173205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.
    Gakis G; Boorjian SA; Briganti A; Joniau S; Karazanashvili G; Karnes RJ; Mattei A; Shariat SF; Stenzl A; Wirth M; Stief CG
    Eur Urol; 2014 Aug; 66(2):191-9. PubMed ID: 23735200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic Radical Prostatectomy Plus Extended Lymph Node Dissection in Combination With Immediate Androgen Deprivation Therapy for Cases of pT3-4N0-1M0 Prostate Cancer: A Multimodal Study of 8 Years' Follow-up.
    Yang Y; Luo Y; Hou GL; Huang QX; Pang J; Gao X
    Clin Genitourin Cancer; 2016 Aug; 14(4):e321-7. PubMed ID: 26691668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective study.
    Castelli T; Russo GI; Favilla V; Urzi D; Spitaleri F; Reale G; Giardina R; Saita A; Madonia M; Cimino S; Morgia G
    Int Braz J Urol; 2014; 40(3):322-9. PubMed ID: 25010298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy.
    Bravi CA; Droghetti M; Fossati N; Gandaglia G; Suardi N; Mazzone E; Cucchiara V; Scuderi S; Barletta F; Schiavina R; Osmonov D; Juenemann KP; Boeri L; Karnes RJ; Kretschmer A; Buchner A; Stief C; Hiester A; Nini A; Albers P; Devos G; Joniau S; Van Poppel H; Grubmüller B; Shariat SF; Heidenreich A; Pfister D; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A
    Eur Urol Oncol; 2022 Jun; 5(3):285-295. PubMed ID: 34176768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up.
    Gandaglia G; Fossati N; Stabile A; Bandini M; Rigatti P; Montorsi F; Briganti A
    Eur Urol; 2017 Aug; 72(2):289-292. PubMed ID: 27574820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-term oncologic outcomes of radical prostatectomy in lymph node metastatic prostate cancer patients.
    Berchiche W; Long Depaquit T; Baboudjian M; Barret É; Rozet F; Cathelineau X; Bastide C
    Prog Urol; 2023 Aug; 33(8-9):437-445. PubMed ID: 37248105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer.
    Fujimoto N; Shiota M; Tomisaki I; Minato A; Yahara K
    Urol Int; 2019; 103(2):125-136. PubMed ID: 31039571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized and Simplified Robot-assisted Superextended Pelvic Lymph Node Dissection for Prostate Cancer: The Monoblock Technique.
    Mattei A; Würnschimmel C; Baumeister P; Hyseni A; Afferi L; Moschini M; Mordasini L; Grande P
    Eur Urol; 2020 Sep; 78(3):424-431. PubMed ID: 32327264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.
    Heidenreich A; Fossati N; Pfister D; Suardi N; Montorsi F; Shariat S; Grubmüller B; Gandaglia G; Briganti A; Karnes RJ
    Eur Urol Oncol; 2018 May; 1(1):46-53. PubMed ID: 31100228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.
    Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
    World J Urol; 2018 Jan; 36(1):15-20. PubMed ID: 29116393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of extended pelvic lymphadenectomy with radical prostatectomy for high-risk prostate cancer.
    Harbin AC; Eun DD
    Urol Oncol; 2015 May; 33(5):208-16. PubMed ID: 25547974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
    Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review.
    Yuh B; Artibani W; Heidenreich A; Kimm S; Menon M; Novara G; Tewari A; Touijer K; Wilson T; Zorn KC; Eggener SE
    Eur Urol; 2014 May; 65(5):918-27. PubMed ID: 23721959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological control in high-risk prostate cancer after radical prostatectomy and salvage radiotherapy compared to radiotherapy plus primary hormone therapy.
    Caño-Velasco J; Herranz-Amo F; Barbas-Bernardos G; Polanco-Pujol L; Verdú-Tartajo F; Lledó-García E; Hernández-Fernández C
    Actas Urol Esp (Engl Ed); 2019 May; 43(4):190-197. PubMed ID: 30878158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer.
    Doan P; Katelaris A; Scheltema MJ; Hayen A; Amin A; Siriwardana A; Tran M; Geboers B; Gondoputro W; Haynes AM; Matthews J; Delprado W; Stricker PD; Thompson J
    BMC Urol; 2023 Apr; 23(1):68. PubMed ID: 37118731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.